Active Pharmaceutical Ingredients and High Potency API Industry | Forecast 2030
Active Pharmaceutical Ingredients and High Potency API Industry Data Book Covers Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Markets.
The global API and HPAPI markets combine to account for USD 233.31 billion revenue in 2021, which is expected to reach USD 393.65 billion by 2030, growing at a cumulative rate of 6.0% over the forecast period.
Grand View Research’s API and High Potency API industry databook is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.
Active Pharmaceutical Ingredients Market Insights
The global active pharmaceutical ingredients market size was valued at USD 222.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.90% from 2023 to 2030.
The captive API segment accounted for the largest revenue share of 51.5% in 2022. It is anticipated to grow at a significant rate in the upcoming years owing to the easy availability of raw materials and extensive investments by major players to develop high-end manufacturing facilities. Furthermore, recent developments and initiatives by key players suggest that they are highly focused on in-house manufacturing over outsourcing.
Innovative APIs held the largest share of 47.07% in 2022. This growth is attributed to increasing R&D initiatives for novel drug development and favorable government regulations. As a result of extensive research in this field, several innovative products are now in development and are expected to launch in the forecast period. New entrants in this segment are expected to drive market growth.
The cardiovascular diseases segment accounted for the largest revenue share of 21.54% in 2022. This is attributed to the increasing prevalence of target diseases worldwide. Various organizations such as the World Heart Federation, the World Stroke Organization, and the Stroke Association are working toward increasing awareness about cardiovascular diseases. Government initiatives such as the National Cholesterol Education Program are aimed at improving awareness related to lipid and cholesterol-related diseases.
The synthetic API segment accounted for the largest revenue share of 72.6% in 2021. This is attributed to the higher availability of raw materials and easier protocols for the synthesis of these molecules. Many synthetic molecules are also expected to go off-patent in the coming years, which is anticipated to boost growth.
Access the Global Active Pharmaceutical Ingredients and High Potency API Industry Data Book, 2022 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory & technological framework studies
High Potency Active Pharmaceutical Ingredients Market Insights
The global high potency active pharmaceutical ingredients market size was estimated at USD 25.17 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030.
The synthetic segment accounted for the largest revenue share in the HPAPI market in 2022. The growth of this segment is due to the higher effectiveness in treatment offered by synthetic HPAPI for a wide range of diseases at very small dosages. Moreover, with the expiry of patents associated with synthetic molecules, there is an increasing entry of generics into the market.
In-house segment held the largest market share in the HPAPI market in 2022. The dominance of the segment is due to the initiatives taken by key players for the development of products suggests that they are highly focused on in-house manufacturing over outsourcing.
Innovative drugs accounted for the largest revenue share in the HPAPI market owing to the growing focus on personalized and precision medicines, such as Antibody-Drug Conjugates (ADCs), the creation of innovative HPAPIs to treat certain patient diseases, making innovation in this field a market driver for the growth of the market. In May 2021, Zydus Cadila launched the first biosimilar antibody-drug conjugate trastuzumab emtansine under the brand name Ujvira.
Oncology segment dominated the market with the largest market share in 2022 and is expected to be the fastest-growing segment. This can be attributed to the increasing prevalence of cancer worldwide. For instance, according to GLOBOCAN 2020, an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred in 2020.
Active Pharmaceutical Ingredients and High Potency API Market – Global Industry Segmentation
API and HPAPI Industry, By Type of Synthesis
- Biotech
- Synthetic
API and HPAPI Industry, By Type of Manufacturer
- Captive APIs
- Merchant APIs
API and HPAPI Industry, By Type
- Generic APIs
- Innovative APIs
API and HPAPI Industry, By Application
- Cardiovascular Diseases
- Oncology
- CNS and Neurology
- Orthopedic
- Endocrinology
- Pulmonology
- Gastroenterology
- Nephrology
- Ophthalmology
- Others
Order your copy of the Free Sample of “Active Pharmaceutical Ingredients and High Potency API Industry Data Book - Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Active Pharmaceutical Ingredients and High Potency API Industry Data Book Regional Outlook
- North America
- S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Denmark
- Norway
- Sweden
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Thailand
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Rest of MEA
Active Pharmaceutical Ingredients and High Potency API Industry Data Book Competitive Landscape
Competitive rivalry in this market is likely to be high due to increasing interest in small molecules and biologics for the treatment of chronic diseases is attracting industry players.
Key players operating in the active pharmaceutical ingredients and high potency API industry are –
- Teva Pharmaceutical Industries Ltd.
- AbbVie, Inc.
- BASF SE
- Boehringer Ingelheim International GmbH
- CordenPharma
- Merck & Co., Inc.
- Reddy’s Laboratories Ltd.
- Cipla, Inc.
- Bristol-Myers Squibb Company
- Sun Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer, Inc.
- Viatris Inc.
- Albemarle Corporation
- Aurobindo Pharma
Go through the table of content of Active Pharmaceutical Ingredients and High Potency API Industry Data Book to get a better understanding of the Coverage & Scope of the study
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Industry OVERVIEW OF Active Pharmaceutical Ingredients(API) MARKET 2020 TO 2026:The market intelligence report on the Global Active Pharmaceutical Ingredients(API) Market offers accurate insights into the industry relating to the leading segments, product types, applications, and the leading geographic regions studied in this report, along with the market value, capacity, production, consumption, gross revenue, market dynamics, and forecast until the year 2026.
The Global Active Pharmaceutical Ingredients(API) Market is expected to deliver a steady growth rate in the forecast duration from 2020 to 2026.
Additionally, the report also gives a historical analysis of the market to use that data to predict future growth trends.In market segmentation by manufacturers, the report covers the following companies-Pfizer, Novartis International, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical, Eli Lilly and Company, GlaxoSmithKline, Merck & Co, AbbVie, Johnson & Johnson, Bayer, Sun Pharmaceutical Industries, DSM, Hisun Pharmacy, Huahai Pharmaceutical, North China Pharmaceutical Group, Shandong Lukang Pharmaceutical, Haerbin Pharmaceutical Group, Shandong Xinhua Pharmaceutical, Jiangsu Hengrui Medicine, Lonza Group, Aurobindo Pharma, Lupin, Biocon, OthersFurthermore, the research report projects the changes in the supply-demand dynamics, market value, market competition, leading market players, and market estimations from 2020 to 2026.
The report has been created after analyzing its essential information in the overall Global Active Pharmaceutical Ingredients(API) market 2020, the vital market aspects influencing the market growth in the coming years.
Our team of expert analysts has scrutinized the Active Pharmaceutical Ingredients(API) market report by referring to the data provided by leading companies.In market segmentation by types of Active Pharmaceutical Ingredients(API), the report covers-Synthetic APIsBiotech APIsOthersIn market segmentation by applications of the Active Pharmaceutical Ingredients(API), the report covers the following uses-OncologyDiabetesCardiovascular DiseaseCNS and Neurological DisordersEndocrinologyOtherThe following years are used in this study to estimate the size of the Active Pharmaceutical Ingredients(API) market:Historical year: 2016-2018Base year: 2019Estimated year: 2020Forecast years: 2020 to 2026Scope of the Research:The report offers an in-depth assessment of the competitive scenario, taking into consideration the market shares held by leading companies.
It also discusses the supply-demand dynamics and key participants with vital business intelligence and helps them with a research-backed forecast for the global Active Pharmaceutical Ingredients(API) market.The evaluation includes the forecast, a summary of the competitive landscape, the market shares of competitors, as well as the market trends, demands, opportunities and challenges existing in the sector, and elaborate product analysis.
The global Active Pharmaceutical Ingredient (API) market size was worth at USD 134.2 billion in the year 2015 which is anticipated to reach a value of USD 239.8 billion by 2025, with CAGR of 6.0%.
Expiration of patent results in increasing focus for development of generic versions of the molecules.
Download Free Sample Report @ https://www.millioninsights.com/industry-reports/active-pharmaceutical-ingredients-api-market/request-sample Synthesis Type Insights Based on synthesis type, the market is categorized into synthetic and biotech.
In 2015, synthetic segment held the largest share.
Manufacturer Type Insights Based on the type of manufacturer, it is categorized into outsourced or merchant or in-house or captive APIs.
Owing of high rate of prescription, high drug development initiatives, and high price, the innovative APIs segment dominated in 2015.
Global Duloxetine API Market” that contains the information from 2015 to 2023.
Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical dosage forms such as tablets and capsules.
Additionally, duloxetine API is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to disease conditions such as arthritis, fibromyalgia, and chronic back pain.The factors such as the rising prevalence of depression, growing penetration of generic drugs, growing cases of anxiety, the growing trend of outsourcing, strong drug pipeline, and increasing demand for newly developed small molecule drugs are expected to drive the market growth during the forecast period.Segment analysisThe global duloxetine API market has been segmented into application.
In this region, North America is expected to dominate the market owing to the increasing incidence of chronic diseases such as psychological disorders, diabetes, increasing government focus on generic drugs, and technological advancements in the manufacturing processes of APIs.
In Europe, the market growth is majorly due to the increasing pharmaceutical sector.
In this region, Japan accounted for a market share of 13.7% in 2017.
The global active pharmaceutical ingredients market was valued at US$ 162,000.0 Mn in 2017 and is projected to expand at a cumulative annual growth rate (CAGR) of 5.4% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Global Active Pharmaceutical Ingredients (API)- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2028.’ The report suggests that increase in the use of pharmaceuticals globally is estimated to boost the active pharmaceutical ingredients market between 2018 and 2026.
The market in Europe is projected to expand at a moderate growth rate of 5.0% during the forecast period.
In addition, health care companies are striving to cut hospitalization costs while offering better services to patients in the country.Read Report Overview - https://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.htmlIncrease in Government Prioritization of Biomedical Innovation Globally to Fuel MarketGovernments across the world have prioritized biomedical innovation.
Drugs approved by the FDA are used for the treatment of relapsed or refractory acute lymphoblastic leukemia, relapsed breast cancer, moderate-to-severe plaque psoriasis, advanced or metastatic urothelial carcinoma, acute bacterial skin infections, Chagas disease, open-angle glaucoma or ocular hypertension, type 2 diabetes mellitus, and septic or other distributive shock.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1690Increase in the Incidence of Acute and Chronic Diseases Globally to Fuel MarketRise in the prevalence of cancer, cardiovascular diseases, and diabetes; sedentary lifestyles; and a rise in the aging population are key factors driving the active pharmaceutical ingredients (API) market.
High degree of competition and reduced profitability are the key factors attributed to the increased preference for outsourcing API production over in-house API manufacturing.The Synthetic Chemical API Segment is Projected to Lead the Active Pharmaceutical Ingredients MarketAround 66.0% of the APIs currently available in the market constitute synthetic chemical APIs, popularly known as small molecules.
